SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178879-24-000006
Filing Date
2024-05-09
Accepted
2024-05-09 16:03:24
Documents
63
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fold-20240331.htm   iXBRL 10-Q 807483
2 EX-31.1 fold-03312024xex311.htm EX-31.1 11054
3 EX-31.2 fold-03312024xex312.htm EX-31.2 11130
4 EX-32.1 fold-03312024xex321.htm EX-32.1 8552
  Complete submission text file 0001178879-24-000006.txt   4918986

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fold-20240331.xsd EX-101.SCH 27677
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fold-20240331_cal.xml EX-101.CAL 62311
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fold-20240331_def.xml EX-101.DEF 105793
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fold-20240331_lab.xml EX-101.LAB 481508
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fold-20240331_pre.xml EX-101.PRE 317017
66 EXTRACTED XBRL INSTANCE DOCUMENT fold-20240331_htm.xml XML 668781
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33497 | Film No.: 24930350
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)